Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 Randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids

Journal of Asthma

Volumn 45, Issue 4, 2008, Pages 265-272

  Hampel, Frank C ^a   Martin, Paula ^b   Mezzanotte, William S ^b  

^a Central Texas Health Research   (United States)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Asthma; Bronchodilation; Crossover study; Formoterol; Salmeterol

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; EXPECTORANT AGENT; FLUTICASONE; FLUTICASONE PLUS SALMETEROL; FLUTICASONE PROPIONATE PLUS SALMETEROL; HYDROCORTISONE; MUCOLYTIC AGENT; ORAL CONTRACEPTIVE AGENT; PLACEBO; SALBUTAMOL; SALMETEROL; SYMBICORT TURBUHALER; VITAMIN; ANDROSTANE DERIVATIVE; BRONCHODILATING AGENT; DRUG DERIVATIVE; ETHANOLAMINE DERIVATIVE; FORMOTEROL;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; COUGHING; CROSSOVER PROCEDURE; DISEASE SEVERITY; DIZZINESS; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; DRY POWDER; DYSPNEA; FEMALE; FORCED EXPIRATORY FLOW; HUMAN; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MORNING DOSAGE; MULTICENTER STUDY; NAUSEA; OUTCOME ASSESSMENT; PAINFUL BREATHING; POWDER INHALER; PRESSURE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINUSITIS; TACHYCARDIA; THORAX PAIN; TREATMENT RESPONSE; TREMOR; WHEEZING; COMPARATIVE STUDY; DRUG COMBINATION; FORCED EXPIRATORY VOLUME; INHALATIONAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY;

ADMINISTRATION, INHALATION; ADULT; ALBUTEROL; ANDROSTADIENES; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CROSS-OVER STUDIES; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; METERED DOSE INHALERS;

EID: 43049151515     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900801890505     Document Type: Article

References (19)

1. National Asthma Education and Prevention Program. Expert Panel Report: guidelines for the diagnosis and management of asthma. Update on selected topics-2002. J Allergy Clin Immunol 2002; 110:S141-S219.
2. Global Initiative for Asthma: Global strategy for asthma management and prevention. Revised 2006. Available at: www.ginasthma.org. Accessed November 2006.
3. Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza JR. Improved refill persistency with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol 2004; 113:245-251.
4. Bender B, Milgrom H, Rand C. Nonadherence in asthmatic patients: is there a solution to the problem? Ann Allergy Asthma Immunol 1997; 79:177-186.
5. Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. Drugs 2006; 66:2235-2254.
6. Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A, for the Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337:1405-1411.
7. Corren J, Korenblat PE, Miller CJ, O'Brien CD, Mezzanotte WS. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. Clin Ther 2007; 29:823-843.
8. Ankerst J, Lötvall J, Cassidy S, Byrne N. Comparison of the bronchodilating effects of formoterol and albuterol delivered by hydrofluoroalkane pressurized metered-dose inhaler. Treat Respir Med 2005; 4:123-127.
9. Seberová E, Andersson A. Oxis® (formoterol given by Turbuhaler®) showed as rapid an onset of action as salbutamol given by a pMDI. Respir Med 2000; 94:607-611.
10. Grembiale RD, Pelaia G, Naty S, Vatrella A, Tranfa CME, Marsico SA. Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients. Pulm Pharmacol Ther 2002; 15:463-466.
11. Palmqvist M, Arvidsson P, Beckman O, Peterson S, Lötvall J. Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers. Pulm Pharmacol Ther 2001; 14:29-34.
12. van der Woude HJ, Boorsma M, Bergqvist PBF, Winter TH, Aalbers R. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction. Pulm Pharmacol Ther 2004; 17:89-95.
13. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Resp Dis. 1987;136:225-244.
14. Bender BG, Bender SE. Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin N Am 2005; 25:107-130.
15. Lai CKW, de Guia TS, Kim Y-Y, et al, on behalf of the Asthma Insights and Reality in Asia-Pacific Steering Committee. Asthma, rhinitis, other respiratory diseases. Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. J Allergy Clin Immunol 2003;111:263-268.
16. Cockcroft DW, Jokic R, Marciniuk DD, Fitzpatrick MF. The current dilemma with spirometric inclusion criteria for asthma drug trials. Ann Allergy Asthma Immunol 1997; 79:226-228.
17. Politiek MJ, Boorsma M, Aalbers R. Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction. Eur Respir J 1999; 13:988-992.
18. van Noord JA, Smeets JJ, Raaijmakers JAM, Bommer AM, Maesen FPV. Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. Eur Respir J 1996; 9:1684-1688.
19. Balanag VM, Yunus F, Yang P-C, Jorup C. Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. Pulm Pharmacol Ther 2006; 19:139-147.